All filters
Abstracts
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA seroconversion and genetically linked HCV infections
P. Mateu-Gelabert  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Cost Effectiveness of expanding treatment with Direct Acting Antiviral treatment to reduce Hepatitis C incidence among HIV infected MSM in Thailand
S. Mukherjee Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Missed Opportunities for HCV Elimination in Provincial Correctional Institutions in Ontario, Canada
P. Ioudovski Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Reduction of hepatitis C burden in Islamabad, Pakistan slums through CHW screen and treat programs
H. Mahmood  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
HCV elimination in France. The countdown has started
V. de Ledinghen  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Models of Care: Strategies towards Elimination of Hepatitis C in Iceland
R. Fridriksdottir  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
The TREAT-B score predicts disease progression in Ethiopian patients with chronic hepatitis B
A. Johannessen Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Expression of HBV-infection markers in placenta of women with chronic hepatitis B
M. Belopolskaia  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Eliminating hepatitis B virus infection in west African migrants living in Barcelona: a community-based testing and vaccination model of care to link patients to liver specialists
C. Picchio Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Enabling HCV scale up through the introduction of a simplified testing approach in Delhi: The HEAD-Start project
D. Soni Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Changes in hepatic fibrosis stages after achieving SVR following direct acting antiviral treatment in children with chronic hepatitis C
R. Soliman Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
External validation of GES score to predict HCC risk in patients with HCV associated significant hepatic fibrosis following DAAs in genotype 1 and 2 in Japan.
G. Shiha Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Decentralized testing and treatment of hepatitis C in people who inject drugs– the Shared Addiction Care Copenhagen (SACC) project
C. Sølund Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A novel hepatitis C intervention in Denmark to test and treat people who inject drugs
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Collocating Hepatitis C Care at Syringe Exchange Programs: Hepatitis C treatment with Less Stigma.
Y. Aponte-Melendez Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Re-linkage to care: a novel strategy to achieve hepatitis C elimination in a University Hospital
M. Mendizabal  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Recall of HCV patients lost to follow-up. ReLinK study in two expert centres in France
V. de Ledinghen  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A successful hepatitis C outreach service in a medically supervised injecting room: increased uptake of screening and high rates of treatment initiation
M. Macisaac Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Dual Sofosbuvir/Daclatasvir Therapy for Chronic Hepatitis C Infection: Lessons from Our Studies in Pediatric Age Groups
M. Yakoot Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015 – June 2020
T. Tsertsvadze  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A Novel Approach Continuum from Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations
T. Stainbrook Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Risks factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia
C. Saing Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A Model for Collaborative Care to Increase Testing and Treatment of HCV in a Shelter Population During COVID-19
N. Gale Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Concordance between FibroScan® and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia
T. Soek-Siam Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020